The Invisible Barrier: Why Thousands of Kidney Patients Never Reach the Transplant List
For hundreds of thousands of Americans living with kidney failure, the path to a life-saving transplant is a marathon of medical bureaucracy. However, a groundbreaking new study reveals that for a vast majority of these patients, the race ends before it ever truly begins.
A comprehensive analysis led by researchers at NYU Langone Health has uncovered a sobering reality: nearly 50% of patients referred for a kidney transplant never even initiate the mandatory evaluation process. Even more concerning, fewer than one in five—just 19%—successfully navigate the gauntlet of medical screenings, administrative hurdles, and logistical challenges required to secure a place on the national transplant waitlist.
The study, published in the Journal of the American Society of Nephrology, stands as the largest and most detailed examination of kidney transplant "dropout" rates to date. By tracking over 720,000 patient records, researchers have pulled back the curtain on a systemic failure that disproportionately impacts the most vulnerable members of society.
The Anatomy of the Evaluation Process
To understand why so many patients fall out of the system, one must first understand the complexity of the "evaluation." Once a patient is referred for a kidney transplant, they do not simply get added to a list. Instead, they must undergo an extensive medical assessment designed to determine their physiological suitability for surgery.
This process is, by definition, a grueling endurance test. It typically involves a battery of blood tests, advanced cardiac imaging, comprehensive cancer screenings, and psychological evaluations. For patients already tethered to a rigid dialysis schedule—often requiring three sessions a week, each lasting four hours—the time commitment is staggering.
"The transplant evaluation process is not just a medical hurdle; it is an administrative and logistical burden," says Dr. Conor Donnelly, the study’s lead author and a PhD student at the NYU Grossman School of Medicine. "Patients are expected to coordinate multiple specialist appointments, secure transportation, and manage complex insurance authorizations while simultaneously managing the exhaustion that comes with chronic kidney disease."
When a patient misses a test or cannot secure a ride to a specialized clinic, they often drop out of the pipeline. The study suggests that for many, the cumulative weight of these requirements becomes an insurmountable barrier to reaching the operating room.
A Chronology of Disparity: Data and Demographics
The research team utilized the Epic Cosmos database, an expansive repository of more than 300 million electronic health records from over 1,850 hospitals across the United States. By analyzing data from 2014 to 2025, the team was able to map the journey of patients through four distinct stages: referral, evaluation, waitlist, and transplant.
The findings highlight a clear, albeit troubling, pattern of inequality. The likelihood of a patient successfully reaching the waitlist is heavily dictated by their socio-economic standing and geography:
- Social Vulnerability: Patients who are unmarried or lack a robust support system face significant challenges. The study notes that the need for a "caregiver" to assist with post-operative recovery is often a tacit requirement for being listed. Without someone to drive them to appointments or assist with medication management, many patients are deemed "too risky" by transplant programs.
- Geographic Factors: Where a patient lives is a major determinant of their survival. Those residing in rural communities or in the Southern United States were found to be less likely to advance through the process. Smaller transplant centers in these regions often operate with fewer resources, leading to more conservative and selective listing criteria compared to larger, urban academic medical centers.
- Demographic Disparities: The data reveals that older adults, Spanish speakers, and those with lower income levels face the steepest climb. These groups frequently contend with a "compounding effect" of barriers, where limited access to transportation and language services intersects with the complexity of the medical system.
- Medical Comorbidities: Patients with severe obesity often face systemic biases or strict BMI cut-offs at various centers, which can halt their progress toward the list, effectively excluding them from the opportunity for a donor organ.
The Institutional Perspective: Why Centers Are Selective
A critical component of the study involves the role of transplant centers themselves. Smaller programs, which may have limited surgical staff or lower donation rates, are often forced to prioritize "ideal" candidates to maintain their success statistics.
"We observed that the specific transplant center a patient is referred to acts as a bottleneck," Dr. Donnelly explains. "If a program has fewer resources, they may be more selective about whom they place on the waitlist. This creates a geography of inequality where your zip code or your local hospital’s institutional policy can determine whether you live or die waiting for a kidney."
This selection bias, while perhaps intended to ensure the success of individual transplants, inadvertently contributes to a massive population of patients who are "de-listed" or who never even begin the process of being listed. These patients remain trapped on long-term dialysis, a treatment that carries a significantly higher mortality risk and a much lower quality of life compared to a successful transplant.
Official Responses and Implications
The medical community has reacted to these findings with a mix of alarm and a call to action. The study’s senior authors emphasize that the current "referral-to-waitlist" pipeline is fundamentally broken.
"Our findings highlight the need to better support patients in progressing from referral to the waitlist, where many possibly eligible individuals are not ultimately listed," says Dr. Michal A. Mankowski, co-senior author of the study.
The researchers advocate for a paradigm shift in how transplantation is managed. Rather than treating the evaluation process as a hurdle the patient must jump over alone, they suggest a more collaborative, "navigator-based" model. This would involve assigning patient advocates or social workers to help those referred for a transplant manage the logistical complexities of the evaluation phase.
"Providing patients with better education and support to help them navigate the complex and sometimes grueling process would be a good start," says Dr. Allan B. Massie, co-senior author. "We need to reduce the friction in the system. Whether it is improving transportation access, offering remote testing options, or standardizing evaluation criteria across the country, we must find ways to ensure that being ‘eligible’ for a kidney actually translates into being ‘on the list’ for one."
Future Research: Beyond the Kidney
The implications of this study extend well beyond the field of nephrology. As the team at NYU Grossman School of Medicine looks to the future, they plan to apply this same rigorous methodology to other forms of organ transplantation, including heart, liver, and lung transplants.
"The path to the waitlist is different for every organ, but the systemic barriers—social, economic, and geographic—are likely universal," says Dr. Mankowski. By identifying exactly where patients drop out of the process, the researchers hope to build a blueprint for reform that can be implemented nationwide.
The study has already sparked discussion at the American Transplant Congress, where the data was presented to top surgeons and transplant administrators. The consensus is clear: the industry can no longer blame the patients for "failing" to complete their evaluations. Instead, the focus must shift to fixing the structural, societal, and institutional barriers that prevent them from accessing the care they need.
As of now, the 48% of patients who never even start their evaluation remain the "forgotten" cohort in the national transplant narrative. For these individuals, the promise of a donor organ is not just a long wait—it is a closed door. The findings from the NYU Langone team provide the evidence necessary to begin the long, difficult process of unlocking that door for everyone.
Study Details and Disclosure
The research was funded by NYU Langone Health. Additional contributors to the study included Suhani Patel, MPH; Syed Ali Husain, MD, MPH; Sommer E. Gentry, PhD; Bonnie E. Lonze, MD, PhD; Sunjae Bae, MD, PhD; Babak J. Orandi, MD, PhD; Mara A. McAdams DeMarco, PhD; and Dorry L. Segev, MD, PhD. External collaborators included Dr. Rachel Patzer of Indiana University and Dr. David Axelrod of University Hospitals in Cleveland. Dr. Babak J. Orandi disclosed a relationship with Boehringer Ingelheim, which is managed by NYU Langone Health’s conflict-of-interest policies.
